Nirvana Life Sciences Inc — Investor Relations & Filings

Nirvana Life Sciences Inc. is a scientific research and development company focused on creating novel therapeutic products derived from psychedelics, primarily psilocybin. The company's core mission is twofold: to develop non-addictive medicines capable of breaking human addiction to opioids, and to create non-addictive pain relief alternatives to replace opioid medications. Utilizing proprietary formulations and extraction technologies, Nirvana is conducting pre-clinical trials to validate the efficacy of its psilocybin-based compounds for addiction treatment, chronic pain management, anxiety, and depression. The company aims to provide effective, non-addictive solutions to address the global opioid crisis.